Virtu KCG Holdings’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $42K | Buy |
11,311
+187
| +2% | +$694 | ﹤0.01% | 2621 |
|
|
2017
Q1 | $46K | Sell |
11,124
-23,239
| -68% | -$96.1K | ﹤0.01% | 2840 |
|
|
2016
Q4 | $148K | Buy |
34,363
+11,400
| +50% | +$49.1K | ﹤0.01% | 2734 |
|
|
2016
Q3 | $226K | Buy |
22,963
+15,425
| +205% | +$152K | 0.01% | 2241 |
|
|
2016
Q2 | $43K | Sell |
7,538
-7,978
| -51% | -$45.5K | ﹤0.01% | 2695 |
|
|
2016
Q1 | $118K | Sell |
15,516
-5,212
| -25% | -$39.6K | ﹤0.01% | 2278 |
|
|
2015
Q4 | $276K | Buy |
20,728
+16,546
| +396% | +$220K | ﹤0.01% | 1827 |
|
|
2015
Q3 | $69K | Sell |
4,182
-12,702
| -75% | -$210K | ﹤0.01% | 2454 |
|
|
2015
Q2 | $379K | Buy |
16,884
+14,841
| +726% | +$333K | 0.01% | 1413 |
|
|
2015
Q1 | $20K | Sell |
2,043
-4,916
| -71% | -$48.1K | ﹤0.01% | 2449 |
|
|
2014
Q4 | $79K | Buy |
6,959
+2,428
| +54% | +$27.6K | ﹤0.01% | 2417 |
|
|
2014
Q3 | $52K | Buy |
4,531
+401
| +10% | +$4.6K | ﹤0.01% | 2429 |
|
|
2014
Q2 | $80K | Sell |
4,130
-7,970
| -66% | -$154K | ﹤0.01% | 2323 |
|
|
2014
Q1 | $216K | Sell |
12,100
-664
| -5% | -$11.9K | ﹤0.01% | 1780 |
|
|
2013
Q4 | $134K | Buy |
12,764
+6,686
| +110% | +$70.2K | ﹤0.01% | 2131 |
|
|
2013
Q3 | $75K | Buy |
+6,078
| New | +$75K | ﹤0.01% | 2333 |
|